Replimune Group, Inc. (REPL)Healthcare | Biotechnology | Woburn, United States | NasdaqGS
2.17 USD
-0.02
(-0.913%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.15 -0.02 (-0.020%) ⇩ (April 17, 2026, 7:59 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:22 a.m. EDT
REPL is a classic post-FDA disaster stock trading at a massive short sellers' discount, relying entirely on speculative retail hope. The stock has collapsed 75% in A short-term price recovery is unlikely until the binary $1 strike floor absorbs the aggressive put volume, and the long-term thesis is effectively dead until a new pipeline product breaks PR-0 trials or a major strategic acquisition occurs. Investors should view this as a high-risk, lottery-ticket trade with no income value and significant downside tail risk from 'second rejection' headlines or cash-burn concerns. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.176518 |
| MSTL | 0.176743 |
| AutoARIMA | 0.178526 |
| AutoETS | 0.178526 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 9% |
| H-stat | 62.42 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 5.87 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 36.262 |
| Market Cap | 179,182,576 |
| Forward P/E | -1.04 |
| Beta | 0.74 |
| Website | https://www.replimune.com |
As of April 19, 2026, 12:22 a.m. EDT: Options data reveals a speculative battleground focused on $1.85 stock. Call speculators are heavily positioned in OTM strikes ($5.00 - $10.00), indicating a binary 'hope' play for catalysts or a recovery to the 52-week high. However, the put activity provides a stark contrast: massive Open Interest (OJ) concentration in ATM ($1.00 - $2.00) and OTM puts ($1.00 - $8.00) across multiple months (0-7 months). The high IV at $1.00 strikes suggests a significant hedging program or aggression positioning the floor. This standoff implies extreme uncertainty; while long gamma exists for a boom, the overwhelming put weight at the $1.50-$2.50 ground floor suggests the market is prepared for further distress or that the current price is a resistance ceiling for longs.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7524244 |
| Address1 | 500 Unicorn Park Drive |
| Address2 | Suite 303 |
| All Time High | 54.85 |
| All Time Low | 1.5 |
| Ask | 2.19 |
| Ask Size | 22 |
| Audit Risk | 10 |
| Average Analyst Rating | 3.6 - Underperform |
| Average Daily Volume10 Day | 14,547,320 |
| Average Daily Volume3 Month | 3,587,559 |
| Average Volume | 3,587,559 |
| Average Volume10Days | 14,547,320 |
| Beta | 0.744 |
| Bid | 2.14 |
| Bid Size | 101 |
| Board Risk | 8 |
| Book Value | 2.644 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.17 |
| Current Ratio | 5.597 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.27 |
| Day Low | 2.09 |
| Debt To Equity | 36.262 |
| Display Name | Replimune |
| Earnings Call Timestamp End | 1,747,915,200 |
| Earnings Call Timestamp Start | 1,747,915,200 |
| Earnings Timestamp | 1,770,125,400 |
| Earnings Timestamp End | 1,779,366,600 |
| Earnings Timestamp Start | 1,779,366,600 |
| Ebitda | -318,880,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.043 |
| Enterprise Value | -13,608,417 |
| Eps Current Year | -3.298 |
| Eps Forward | -2.082 |
| Eps Trailing Twelve Months | -3.44 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.9646 |
| Fifty Day Average Change | -4.7946 |
| Fifty Day Average Change Percent | -0.6884243 |
| Fifty Two Week Change Percent | -75.24244 |
| Fifty Two Week High | 13.24 |
| Fifty Two Week High Change | -11.07 |
| Fifty Two Week High Change Percent | -0.8361027 |
| Fifty Two Week Low | 1.5 |
| Fifty Two Week Low Change | 0.6700001 |
| Fifty Two Week Low Change Percent | 0.44666672 |
| Fifty Two Week Range | 1.5 - 13.24 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,532,093,400,000 |
| Float Shares | 62,901,344 |
| Forward Eps | -2.082 |
| Forward P E | -1.0422671 |
| Free Cashflow | -172,752,880 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 479 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0272 |
| Held Percent Institutions | 0.97405 |
| Implied Shares Outstanding | 82,572,619 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Long Business Summary | Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. |
| Long Name | Replimune Group, Inc. |
| Market | us_market |
| Market Cap | 179,182,576 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_571664452 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -314,852,992 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 179,182,583 |
| Number Of Analyst Opinions | 6 |
| Open | 2.21 |
| Operating Cashflow | -277,913,984 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 781 222 9600 |
| Post Market Change | -0.01999998 |
| Post Market Change Percent | -0.9216581 |
| Post Market Price | 2.15 |
| Post Market Time | 1,776,470,376 |
| Previous Close | 2.19 |
| Price Eps Current Year | -0.65797454 |
| Price Hint | 4 |
| Price To Book | 0.82072616 |
| Profit Margins | 0.0 |
| Quick Ratio | 5.432 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | underperform |
| Recommendation Mean | 3.625 |
| Region | US |
| Regular Market Change | -0.02 |
| Regular Market Change Percent | -0.913241 |
| Regular Market Day High | 2.27 |
| Regular Market Day Low | 2.09 |
| Regular Market Day Range | 2.09 - 2.27 |
| Regular Market Open | 2.21 |
| Regular Market Previous Close | 2.19 |
| Regular Market Price | 2.17 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 5,867,838 |
| Return On Assets | -0.43242002 |
| Return On Equity | -0.90878 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 82,572,619 |
| Shares Percent Shares Out | 0.19780001 |
| Shares Short | 16,335,211 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 15,870,235 |
| Short Name | Replimune Group, Inc. |
| Short Percent Of Float | 0.35459998 |
| Short Ratio | 10.18 |
| Source Interval | 15 |
| State | MA |
| Symbol | REPL |
| Target High Price | 10.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 3.5 |
| Target Median Price | 2.0 |
| Total Cash | 269,136,992 |
| Total Cash Per Share | 3.259 |
| Total Debt | 76,346,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.44 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.346675 |
| Two Hundred Day Average Change | -5.176675 |
| Two Hundred Day Average Change Percent | -0.7046283 |
| Type Disp | Equity |
| Volume | 5,867,838 |
| Website | https://www.replimune.com |
| Zip | 1,801 |